Skip to main content


Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

Fig. 2

Effect of aspirin on the primary prevention of major adverse cardiovascular events, all-cause mortality, myocardial infarction, coronary heart disease, stroke, and cardiovascular disease death, in people with diabetes. CI, confidence interval (bars); CHD, coronary heart disease; CVD, cardiovascular disease; MACE, major adverse cardiovascular events; RR, relative risk

Back to article page